|
CCDC109A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.56370000000373E-05 |
| Normal-vs-Stage3 |
2.26190000000015E-05 |
| Normal-vs-Stage4 |
6.161900E-04 |
| Stage1-vs-Stage2 |
6.550200E-01 |
| Stage1-vs-Stage3 |
4.299200E-01 |
| Stage1-vs-Stage4 |
9.700600E-01 |
| Stage2-vs-Stage3 |
4.176800E-01 |
| Stage2-vs-Stage4 |
8.171400E-01 |
| Stage3-vs-Stage4 |
6.352000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.68187686000465E-12 |
| Normal-vs-Asian |
5.348000E-02 |
| Caucasian-vs-AfricanAmerican |
4.526000E-02 |
| Caucasian-vs-Asian |
4.448200E-01 |
| AfricanAmerican-vs-Asian |
8.267200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.14273043752655E-14 |
| Male-vs-Female |
5.791000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.01779999878349E-08 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
2.4953372701475E-12 |
| Normal-vs-Extreme_Obese |
4.378000E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.208500E-02 |
| Normal_Weight-vs-Obese |
2.355600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.292200E-01 |
| Extreme_Weight-vs-Obese |
6.562800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.504600E-01 |
| Obese-vs-Extreme_Obese |
7.896600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.384310E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
9.986700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.355000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.974200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.391000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.881180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.596210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.853200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.06440001257369E-09 |
| Normal-VS-KIRP CIMP |
9.9790000000044E-05 |
| Normal-VS-Unclassified PRCC |
4.66299999724029E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.69419999998632E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.217300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.863400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.779200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.042230E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.532100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.92970000376403E-08 |
| Normal-vs-N1 |
4.40030000000702E-05 |
| Normal-vs-N2 |
9.571900E-02 |
| N0-vs-N1 |
3.860400E-01 |
| N0-vs-N2 |
8.008200E-01 |
| N1-vs-N2 |
8.739200E-01 |
|
|
